Guardant Health, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 9 | -$0.97 | -$0.85 | -$0.88 |
Q2 2024 | 4 | -$0.83 | -$0.73 | -$0.75 |
Q3 2024 | 8 | -$0.81 | -$0.71 | -$0.73 |
Q4 2024 | 10 | -$0.84 | -$0.69 | -$0.78 |
Q1 2025 | 7 | -$0.99 | -$0.61 | -$0.77 |
Q2 2025 | 3 | -$0.82 | -$0.72 | -$0.74 |
Q3 2025 | 6 | -$0.85 | -$0.75 | -$0.77 |
Q4 2025 | 5 | -$0.76 | -$0.67 | -$0.69 |
Q1 2026 | 4 | -$0.69 | -$0.60 | -$0.62 |
Q2 2026 | 3 | -$0.64 | -$0.56 | -$0.58 |
Q3 2026 | 2 | -$0.72 | -$0.63 | -$0.65 |
Q4 2026 | 2 | -$0.55 | -$0.48 | -$0.50 |
Guardant Health, Inc. Earnings Date And Information
Guardant Health, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-0.45 earnings per share for the quarter, topping analysts' consensus estimates of $-0.55 by $0.1. The company had revenue of 191.48 M for the quarter and had revenue of 563.95 M for the year. Guardant Health, Inc. has generated $-4 earnings per share over the last year ($-4.28 diluted earnings per share) and currently has a price-to-earnings ratio of -7.91. Guardant Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Guardant Health, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/06/2024 | Q3 2024 | -$0.55 | -$0.88 | -0.33 | $170.49 M | $191.48 M |
08/07/2024 | Q2 2024 | -$0.57 | -$0.84 | -0.27 | $162.59 M | $177.24 M |
05/09/2024 | Q1 2024 | -$0.72 | -$0.94 | -0.22 | $168.49 M | |
02/22/2024 | Q4 2023 | -$0.93 | -$1.58 | -0.65 | $155.05 M | |
11/06/2023 | Q3 2023 | -$0.93 | -$0.73 | 0.2 | $137.35 M | $143.03 M |
08/03/2023 | Q2 2023 | -$1.25 | -$0.67 | 0.58 | $129.85 M | $137.15 M |
05/09/2023 | Q1 2023 | -$1.26 | -$1.30 | -0.04 | $128.71 M | |
02/23/2023 | Q4 2022 | -$1.40 | -$1.36 | 0.04 | $126.89 M | |
11/03/2022 | Q3 2022 | -$1.27 | -$1.58 | -0.31 | $117.75 M | $117.40 M |
08/04/2022 | Q2 2022 | -$1.25 | -$2.25 | -1 | $105.08 M | $109.14 M |
05/05/2022 | Q1 2022 | -$1.23 | -$1.21 | 0.02 | $96.10 M | |
02/24/2022 | Q4 2021 | -$0.89 | $108.11 M | |||
11/04/2021 | Q3 2021 | -$0.90 | -$1.06 | -0.16 | $92.01 M | $94.78 M |
08/05/2021 | Q2 2021 | -$0.87 | -$0.96 | -0.09 | $84.52 M | $92.10 M |
05/06/2021 | Q1 2021 | -$0.82 | -$1.09 | -0.27 | $78.67 M | |
02/25/2021 | Q4 2020 | -$0.94 | $78.32 M | |||
11/05/2020 | Q3 2020 | -$0.34 | -$0.78 | -0.44 | $65.93 M | $74.57 M |
08/06/2020 | Q2 2020 | -$0.40 | -$0.57 | -0.17 | $59.18 M | $66.34 M |
05/07/2020 | Q1 2020 | -$0.38 | -$0.29 | 0.09 | $67.51 M | |
03/02/2020 | Q4 2019 | -$0.27 | $62.90 M |
Guardant Health, Inc. Earnings: Frequently Asked Questions
-
When is Guardant Health, Inc.'s earnings date?
Guardant Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
Did Guardant Health, Inc. beat their earnings estimates last quarter?
In the previous quarter, Guardant Health, Inc. (:GH) reported $-0.45 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.55 by $0.1.
-
How can I listen to Guardant Health, Inc.'s earnings conference call?
The conference call for Guardant Health, Inc.'s latest earnings report can be listened to online.
-
How can I read Guardant Health, Inc.'s conference call transcript?
The conference call transcript for Guardant Health, Inc.'s latest earnings report can be read online.
-
How much revenue does Guardant Health, Inc. generate each year?
Guardant Health, Inc. (:GH) has a recorded annual revenue of $563.95 M.
-
How much profit does Guardant Health, Inc. generate each year?
Guardant Health, Inc. (:GH) has a recorded net income of $563.95 M. Guardant Health, Inc. has generated $-4.28 earnings per share over the last four quarters.
-
What is Guardant Health, Inc.'s price-to-earnings ratio?
Guardant Health, Inc. (:GH) has a price-to-earnings ratio of -7.91 and price/earnings-to-growth ratio is 2.16.